We are live on
!
Find out more
WVP
Worth Venture Partners Portfolio holdings
AUM
$31.6M
1-Year Est. Return
28.5%
This Fund
S&P 500
This Quarter
Est. Return
+6.42%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$205M
AUM Growth
+$35.6M
(+21%)
Cap. Flow
-$35.2M
Cap. Flow
% of AUM
-17.19%
Top 10 Holdings %
Top 10 Hldgs %
38.54%
Holding
227
New
51
Increased
39
Reduced
41
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
+$2.06M |
| 2 |
Digital Turbine
APPS
|
+$1.87M |
| 3 |
Merck
MRK
|
+$1.39M |
| 4 |
Pfizer
PFE
|
+$1.11M |
| 5 |
Broadwind
BWEN
|
+$1.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DZSI
DZS Inc. Common Stock
DZSI
|
+$3.66M |
| 2 |
Aspen Aerogels
ASPN
|
+$2.95M |
| 3 |
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
|
+$2.56M |
| 4 |
Evolus
EOLS
|
+$1.72M |
| 5 |
indie Semiconductor
INDI
|
+$1.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.52% |
| 2 | Healthcare | 17.49% |
| 3 | Financials | 5.11% |
| 4 | Real Estate | 2.52% |
| 5 | Industrials | 2.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Cardlytics
CDLX
$23.6M
| $175K | 0.09% |
5,162
-5,161
| -50% | -$270K |
|
102
Asure Software
ASUR
$253M
| $164K | 0.08% |
11,300
+3,800
| +51% | +$44.8K |
|
103
PUT
Sarepta Therapeutics
SRPT
$1.68B
| $156K | 0.08% |
+12,800
| New | +$1.66M |
|
104
Ribbon Communications
RBBN
$379M
| $154K | 0.08% |
45,000
+16,000
| +55% | +$58.5K |
|
|
ASRT
105
DELISTED
Assertio
ASRT
| $148K | 0.07% |
1,547
+1,214
| +365% | +$91.4K |
|
106
Myomo
MYO
$40.2M
| $147K | 0.07% |
+245,580
| New | +$144K |
|
107
DocGo
DCGO
$64M
| $120K | 0.06% |
+13,900
| New | +$123K |
|
|
SQNS
108
Sequans Communications SA
SQNS
$36.5M
| $114K | 0.06% |
2,272
+232
| +11% | +$15.8K |
|
|
GRTS
109
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $107K | 0.05% |
+38,379
| New | +$110K |
|
110
Nokia
NOK
$52.3B
| $98.2K | 0.05% |
20,000
-5,000
| -20% | -$23.6K |
|
111
Lantronix
LTRX
$252M
| $93.8K | 0.05% |
21,612
-5,888
| -21% | -$27.6K |
|
|
AMRS
112
PUT
DELISTED
Amyris Inc.
AMRS
| $90.9K | 0.04% |
170,900
-279,900
| -62% | -$400K |
|
113
PUT
Wayfair
W
$11.8B
| $87.7K | 0.04% |
40,900
+8,600
| +27% | +$381K |
|
|
CTLP
114
DELISTED
Cantaloupe
CTLP
| $77K | 0.04% |
+13,500
| New | +$71.9K |
|
|
NOTE
115
DELISTED
FiscalNote
NOTE
| $73.8K | 0.04% |
+2,758
| New | +$112K |
|
|
ISEE
116
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $68.9K | 0.03% |
115,500
+102,100
| +762% | +$2.24M |
|
117
Ceragon Networks
CRNT
$200M
| $65.1K | 0.03% |
39,000
+4,000
| +11% | +$7.61K |
|
|
VISN
118
Vistance Networks Inc
VISN
$2.72B
| $63.7K | 0.03% |
10,000
+2,000
| +25% | +$15.1K |
|
119
PUT
PTC Therapeutics
PTCT
$5.68B
| $63.4K | 0.03% |
+12,800
| New | +$585K |
|
120
CALL
Arcus Biosciences
RCUS
$3.47B
| $61.1K | 0.03% |
+25,800
| New | +$493K |
|
|
DFSCW
121
DEFSEC Technologies Warrant
DFSCW
| $58.9K | 0.03% |
147,353
| – | – |
|
122
PUT
Carnival Corporation Ltd
CCL
$39.4B
| $57.6K | 0.03% |
137,100
+43,800
| +47% | +$454K |
|
123
PUT
The GEO Group
GEO
$4.19B
| $56.9K | 0.03% |
103,500
+45,800
| +79% | +$449K |
|
|
VCNX
124
DELISTED
Vaccinex, Inc. Common Stock
VCNX
| $55.4K | 0.03% |
661
-1,757
| -73% | -$193K |
|
|
MREO
125
Mereo BioPharma
MREO
$50.4M
| $54.1K | 0.03% |
+76,513
| New | +$68.9K |
|
Similar funds
VL
SP
OGC
PE
RL
AIIC
LGM
SCA
Worth Venture Partners's Q1 2023 Portfolio in Review
As of Q1 2023, Worth Venture Partners held 227 positions worth $205M, up 21% from $169M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Worth Venture Partners withdrew a net $35.2M in Q1 2023, closing 39 positions and reducing 41 holdings. Its most notable exit was Aspen Aerogels, an estimated $2.95M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Worth Venture Partners opened a new position in Marinus Pharmaceuticals, Inc worth $2.27M.
- Worth Venture Partners's largest Q1 2023 buy was Marinus Pharmaceuticals, Inc: 328,735 shares worth $2.27M.
- Worth Venture Partners added most to Digital Turbine in Q1 2023, an estimated $1.87M increase.
- Worth Venture Partners's biggest Q1 2023 reduction was DZS Inc. Common Stock, cutting an estimated $3.66M.
- Worth Venture Partners fully exited Aspen Aerogels in Q1 2023, selling an estimated $2.95M.
- Worth Venture Partners's ten largest holdings make up 39% of its $205M portfolio in Q1 2023.
- Worth Venture Partners opened 51 new positions and closed 39 in Q1 2023.
- Worth Venture Partners's portfolio value rose 21% quarter-over-quarter to $205M.
Based on Worth Venture Partners's 13F filing for Q1 2023, filed 15 May 2023.